Apollomics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Apollomics and other ETFs, options, and stocks.About APLM
Apollomics, Inc. is a clinical-stage biotechnology company, which engages in the discovery and development of oncology therapies to address unmet medical needs. The company was founded by Liang Yu Guo and Sanjeev Redkar in May 2015 and is headquartered in Foster City, CA.
CEOHung Wen Chen
CEOHung Wen Chen
Employees13
Employees13
HeadquartersFoster City, California
HeadquartersFoster City, California
Founded2015
Founded2015
Employees13
Employees13
APLM Key Statistics
Market cap16.74M
Market cap16.74M
Price-Earnings ratio-0.31
Price-Earnings ratio-0.31
Dividend yield—
Dividend yield—
Average volume29.89K
Average volume29.89K
High today$18.90
High today$18.90
Low today$14.80
Low today$14.80
Open price$17.22
Open price$17.22
Volume47.77K
Volume47.77K
52 Week high$42.12
52 Week high$42.12
52 Week low$3.66
52 Week low$3.66
Stock Snapshot
With a market cap of 16.74M, Apollomics(APLM) trades at $15.08. The stock has a price-to-earnings ratio of -0.31.
On 2025-12-17, Apollomics(APLM) stock traded between a low of $14.80 and a high of $18.90. Shares are currently priced at $15.08, which is +1.9% above the low and -20.2% below the high.
The Apollomics(APLM)'s current trading volume is 47.77K, compared to an average daily volume of 29.89K.
During the past year, Apollomics(APLM) stock moved between $3.66 at its lowest and $42.12 at its peak.
During the past year, Apollomics(APLM) stock moved between $3.66 at its lowest and $42.12 at its peak.
People also own
Based on the portfolios of people who own APLM. This list is generated using Robinhood data, and it’s not a recommendation.